SCHEMBL30536136

SCHEMBL30536136

O=C(COc1ccccc1)Nc1ncnc2nc[nH]c12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 13/20 0.63
NT5C2 P49902 2/20 0.58
NT5E P21589 1/20 0.56
LMNA P02545 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
TSHR P16473 1/20 0.55
CDK2 P24941 1/20 0.55
MAPK1 P28482 1/20 0.55
MEN1 O00255 1/20 0.53
NPC1 O15118 1/20 0.53
TP53 P04637 1/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
HTT P42858 1/20 0.53
RAB9A P51151 1/20 0.53
KMT2A Q03164 1/20 0.53
ALPL P05186 1/20 0.51
CREBBP Q92793 1/20 0.51
BRPF1 P55201 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6933558 1.00 BRD4 (0.63) BRD4NT5C2NT5ELMNACYP1A2
SCHEMBL5694112 0.83 NPC1 (0.49) LMNATSHRMEN1NPC1TP53
SCHEMBL38666421 0.82 BRD4 (0.66) BRD4NT5C2NT5ELMNACYP1A2
SCHEMBL5694094 0.82 XDH (0.51) NPC1TP53RAB9A
SCHEMBL6933552 0.81 ALPL (0.52) LMNATSHRNPC1TP53MAPT
SCHEMBL38663949 0.80 BRD4 (0.58) BRD4NT5C2NT5ECYP1A2TSHR
SCHEMBL28828155 0.78 BRD4 (0.59) BRD4NT5C2NT5ECYP1A2TSHR
SCHEMBL23124 0.78 BRD4 (1.00) BRD4NT5C2NT5ENPC1RAB9A
SCHEMBL29514799 0.78 BRD4 (1.00) BRD4NT5C2NT5ENPC1RAB9A
SCHEMBL6463477 0.77 BRD4 (0.92) BRD4NT5C2NT5ECREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11987599-B2 Solid support for synthesizing nucleic acid sequences and methods for making and using UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-05-21 US claimed
US-20230271998-A1 SOLID SUPPORT FOR SYNTHESIZING NUCLEIC ACID SEQUENCES AND METHODS FOR MAKING AND USING UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-08-31 US claimed
US-11987599-B2 Solid support for synthesizing nucleic acid sequences and methods for making and using UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-05-21 US disclosed
US-20230271998-A1 SOLID SUPPORT FOR SYNTHESIZING NUCLEIC ACID SEQUENCES AND METHODS FOR MAKING AND USING UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11987599-B2 Solid support for synthesizing nucleic acid sequences and methods for making and using RNGTT, NSUN2, POLN BRD4 4551/4885NT5C2 494/4885NT5E 425/4885
US-20230271998-A1 SOLID SUPPORT FOR SYNTHESIZING NUCLEIC ACID SEQUENCES AND METHODS FOR MAKING AND USING RNGTT, NSUN2, POLN BRD4 4551/4885NT5C2 494/4885NT5E 425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.